What is the current Price Target for the Tenax Therapeutics, Inc. stock?

The average Tenax Therapeutics, Inc. target price is $5.10. This is 157.58% higher than the current stock price. The highest price target is 1,756.06%, the lowest is 104.04%. 10 Analysts have issued a price target Tenax Therapeutics, Inc. 2027 .

How high will the Tenax Therapeutics, Inc. stock rise?

No reliable answer can be given as to how high the Tenax Therapeutics, Inc. stock will rise. The performance of stocks, including the Tenax Therapeutics, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Tenax Therapeutics, Inc. stock today?

The performance of Tenax Therapeutics, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Tenax Therapeutics, Inc. stock fall?

The decline in Tenax Therapeutics, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Tenax Therapeutics, Inc. Forecast, price target & analysts

$1.99

2.85%

Nasdaq, Oct 02, 04:00 pm EDT. Closed.

ISIN

US88032L2097

Symbol

TENX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Tenax Therapeutics, Inc. Target price 2026 - Analyst rating & recommendation

Tenax Therapeutics, Inc. Classifications & Recommendation

Buy

69%

Hold

31%

Tenax Therapeutics, Inc. Price Target

Target Price	$5.10
Price	$1.98
Potential	157.58% register free of charge
Number of Estimates	10

	10 Analysts have issued a price target Tenax Therapeutics, Inc. 2027 . The average Tenax Therapeutics, Inc. target price is $5.10. This is 157.58% register free of charge higher than the current stock price. The highest price target is $36.75 1,756.06% register free of charge , the lowest is $4.04 104.04% register free of charge .
	A rating was issued by 16 analysts: 11 Analysts recommend Tenax Therapeutics, Inc. to buy, 5 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Tenax Therapeutics, Inc. stock has an average upside potential 2027 of 157.58% register free of charge . Most analysts recommend the Tenax Therapeutics, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-1.34	-1.48
	16.52%	10.45%
P/E		negative

11 Analysts have issued a Tenax Therapeutics, Inc. forecast for earnings per share. The average Tenax Therapeutics, Inc. EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-1.34	16.52%
2026	$-1.48 10.45% unlock
2027	$-1.44 2.70% unlock
2028	$-1.51 4.86% unlock
2029	$-0.81 46.36% unlock
2030	$0.16 119.75% unlock
2031	$1.83 1,043.75% unlock
2032	$3.27 78.69% unlock
2033	$6.19 89.30% unlock

Current	-1.52	83.46%
2026	-1.30 14.46% unlock
2027	-1.34 3.08% unlock
2028	-1.28 4.48% unlock
2029	-2.38 85.94% unlock
2030	12.21 613.03% unlock
2031	1.06 91.32% unlock
2032	0.59 44.34% unlock
2033	0.31 47.46% unlock

Tenax Therapeutics, Inc....

Current Tenax Therapeutics, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Guggenheim	Locked ➜ Locked	Locked	Aug 31 2026
Canaccord Genuity	Locked ➜ Locked	Locked	Aug 11 2026
Chardan Capital	Locked ➜ Locked	Locked	Aug 11 2026
Evercore ISI Group	Locked ➜ Locked	Locked	Aug 11 2026
Guggenheim	Locked ➜ Locked	Locked	Aug 11 2026
William Blair	Locked ➜ Locked	Locked	Aug 10 2026
Chardan Capital	Locked ➜ Locked	Locked	Jul 31 2026

Analyst Rating	Date
Locked Guggenheim: Locked ➜ Locked	Aug 31 2026
Locked Canaccord Genuity: Locked ➜ Locked	Aug 11 2026
Locked Chardan Capital: Locked ➜ Locked	Aug 11 2026
Locked Evercore ISI Group: Locked ➜ Locked	Aug 11 2026
Locked Guggenheim: Locked ➜ Locked	Aug 11 2026
Locked William Blair: Locked ➜ Locked	Aug 10 2026
Locked Chardan Capital: Locked ➜ Locked	Jul 31 2026

Discover more stocks with a high price target

NIO ADR 86.90%

Alibaba Group Holding Ltd 81.89%

Rheinmetall 70.55%

Tencent Holdings Ltd. 61.28%

Adyen 56.67%

Uber Technologies 51.26%

BYD 50.30%

Siemens Energy 43.79%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now